Bandola-Simon J, Ito Y, Wucherpfennig K, Roche P
Cell Rep. 2025; 44(1):115150.
PMID: 39752250
PMC: 11886875.
DOI: 10.1016/j.celrep.2024.115150.
Rodriguez-Gonzalez D, Guillen-Sanchez G, Del Pozo V, Canas J
Int J Mol Sci. 2024; 25(23).
PMID: 39684345
PMC: 11641648.
DOI: 10.3390/ijms252312633.
Berger S, Zeyn Y, Wagner E, Bros M
Microb Biotechnol. 2024; 17(11):e70053.
PMID: 39545748
PMC: 11565620.
DOI: 10.1111/1751-7915.70053.
Poyia F, Neophytou C, Christodoulou M, Papageorgis P
Int J Mol Sci. 2024; 25(17).
PMID: 39273502
PMC: 11395109.
DOI: 10.3390/ijms25179555.
Ren H, Zhu A, Yang W, Jia Y, Cheng H, Wu Y
Adv Sci (Weinh). 2024; 11(40):e2405729.
PMID: 39225346
PMC: 11516112.
DOI: 10.1002/advs.202405729.
Immunogenic cell death-based cancer vaccines: promising prospect in cancer therapy.
Wang J, Ma J, Xie F, Miao F, Lv L, Huang Y
Front Immunol. 2024; 15:1389173.
PMID: 38745666
PMC: 11092378.
DOI: 10.3389/fimmu.2024.1389173.
Recent Findings on Therapeutic Cancer Vaccines: An Updated Review.
Sheikhlary S, Lopez D, Moghimi S, Sun B
Biomolecules. 2024; 14(4).
PMID: 38672519
PMC: 11048403.
DOI: 10.3390/biom14040503.
Current Perspectives in Giant Cell Arteritis: Can We Better Connect Pathogenesis and Treatment?.
Opris-Belinski D, Cobilinschi C, Saulescu I
Medicina (Kaunas). 2024; 60(3).
PMID: 38541126
PMC: 10972181.
DOI: 10.3390/medicina60030400.
Design and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines.
Song K, Pun S
BME Front. 2024; 5:0038.
PMID: 38515636
PMC: 10956738.
DOI: 10.34133/bmef.0038.
Macrophage barrier in the tumor microenvironment and potential clinical applications.
Ji S, Shi Y, Yin B
Cell Commun Signal. 2024; 22(1):74.
PMID: 38279145
PMC: 10811890.
DOI: 10.1186/s12964-023-01424-6.
Interorgan communication with the liver: novel mechanisms and therapeutic targets.
Zhao J, Zhang X, Li Y, Yu J, Chen Z, Niu Y
Front Immunol. 2023; 14:1314123.
PMID: 38155961
PMC: 10754533.
DOI: 10.3389/fimmu.2023.1314123.
Ongoing HIV replication in lymph node sanctuary sites in treated individuals contributes to the total latent HIV at a very slow rate.
Paryad-Zanjani S, Jagarapu A, Piovoso M, Zurakowski R
J Theor Biol. 2023; 575:111651.
PMID: 37898364
PMC: 10680438.
DOI: 10.1016/j.jtbi.2023.111651.
Looking beyond Self-Protection: The Eyes Instruct Systemic Immune Tolerance Early in Life.
Villafan H, Gutierrez-Ospina G
Brain Sci. 2023; 13(9).
PMID: 37759864
PMC: 10526493.
DOI: 10.3390/brainsci13091261.
Research progress of nanovaccine in anti-tumor immunotherapy.
Yao M, Liu X, Qian Z, Fan D, Sun X, Zhong L
Front Oncol. 2023; 13:1211262.
PMID: 37692854
PMC: 10484753.
DOI: 10.3389/fonc.2023.1211262.
Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies.
Hou Y, Chen M, Bian Y, Zheng X, Tong R, Sun X
Acta Pharm Sin B. 2023; 13(8):3321-3338.
PMID: 37655334
PMC: 10465871.
DOI: 10.1016/j.apsb.2023.01.006.
Lenvatinib plus sintilimab with or without transarterial chemoembolization for intermediate or advanced stage hepatocellular carcinoma: a propensity score-matching cohort study.
Lang M, Gan L, Ren S, Han R, Ma X, Li G
Am J Cancer Res. 2023; 13(6):2540-2553.
PMID: 37424821
PMC: 10326569.
Single cell RNA sequencing reveals distinct clusters of Irf8-expressing pulmonary conventional dendritic cells.
Jirmo A, Grychtol R, Gaedcke S, Liu B, DeStefano S, Happle C
Front Immunol. 2023; 14:1127485.
PMID: 37251386
PMC: 10213693.
DOI: 10.3389/fimmu.2023.1127485.
A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma.
Gan L, Lang M, Tian X, Ren S, Li G, Liu Y
J Hepatocell Carcinoma. 2023; 10:673-686.
PMID: 37125392
PMC: 10132469.
DOI: 10.2147/JHC.S404675.
Current Trends in Neoantigen-Based Cancer Vaccines.
Ho S, Chang C, Liao H, Chou W, Guo C, Yen Y
Pharmaceuticals (Basel). 2023; 16(3).
PMID: 36986491
PMC: 10056833.
DOI: 10.3390/ph16030392.
Heterogeneity of Cholangiocarcinoma Immune Biology.
Vita F, Olaizola I, Amato F, Rae C, Marco S, Banales J
Cells. 2023; 12(6).
PMID: 36980187
PMC: 10047186.
DOI: 10.3390/cells12060846.